The import of Chloramphenicol to Canada is forecasted to show a steady upward trend from 2024 to 2028. Starting at 109.63 thousand US dollars in 2024, it is expected to rise to 114.09 thousand US dollars by 2028. This indicates a consistent growth pattern, reflective of a stable demand in the Canadian market.
The year-on-year percentage increase is approximately 1% annually, demonstrating moderate but consistent growth. Compared to the last reported actual data in 2023, this forecasted trajectory suggests a cautious but positive outlook for importers and stakeholders in the Canadian pharmaceutical sector. The compound annual growth rate (CAGR) over this period would align with these incremental increases.
Future trends to watch for include potential shifts in Canadian pharmaceutical regulations, global supply chain dynamics, and advancements in alternative therapeutics that could influence Chloramphenicol demand and import practices. Staying informed about these factors will be crucial for strategic planning and risk management in the sector.
